Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 133-140

  Li, Shijun ^a   Shi, Guangxia ^a   Yuan, Hong ^a   Zhou, Tao ^a   Zhang, Qiuping ^a   Zhu, Hong ^a   Wang, Xiaoyan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; ASPP family of proteins; Non small cell lung cancer; p53

Indexed keywords

APOPTOSIS STIMULATING OF 53 PROTEIN 1; APOPTOSIS STIMULATING OF 53 PROTEIN 2; CISPLATIN; I APOPTOSIS STIMULATING OF 53 PROTEIN; MESSENGER RNA; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL COUNT; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CISPLATIN; DOWN-REGULATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861556609     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1778     Document Type: Article

References (15)

1. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH: Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO 15: 827-838, 1996. (Pubitemid 26064289)
2. Tammemagi MC, McLaughlin JR and Bull SB: Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers. Cancer Epidemiol Biomarkers Prev 8: 625-634, 1999. (Pubitemid 29337324)
3. Mitsudomi T, Hamajima N, Ogawa M and Takahashi T: Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 6: 4055-4063, 2000.
4. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T and Lu X: ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794, 2001. (Pubitemid 33030212)
5. Vives V, Su J, Zhong S, Ratnayaka I, Slee E, Goldin R and Lu X: ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20: 1262-1267, 2006. (Pubitemid 43727587)
6. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T and Lu X: ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24: 1341-1350, 2004. (Pubitemid 38112194)
7. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE and Lu X: iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33: 162-167, 2003. (Pubitemid 36177067)
8. Lettre G, Kritikou EA, Jaeggi M, Calixto A, Fraser AG, Kamath RS, Ahringer J and Hengartner MO: Genome-wide RNAi identifies p53-dependent and -independent regulators of germ cell apoptosis in C. elegans. Cell Death Differ 11: 1198-1203, 2004. (Pubitemid 39529962)
9. Liu ZJ, Lu X, Zhang Y, Zhong S, Gu SZ, Zhang XB, Yang X and Xin HM: Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett 579: 1587-1590, 2005. (Pubitemid 40341527)
10. Mori T, Okamoto H, Takahashi N, Ueda R and Okamoto T: Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines. FEBS Lett 465: 124-128, 2000. (Pubitemid 30021458)
11. Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K and Sekido Y: p53 apoptotic pathway molecules are frequently and simultaneously altered in non-small cell lung carcinoma. Cancer 100: 1673-1682, 2004. (Pubitemid 38456345)
12. Liu ZJ, Zhang Y, Zhang XB and Yang X: Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia 18: 880, 2004. (Pubitemid 38500212)
13. Zhang X, Wang M, Zhou C, Chen S and Wang J: The expression of iASPP in acute leukemias. Leuk Res 29: 179-183, 2005. (Pubitemid 39647513)
14. Zhao J, Wu GB, Bu FF, Lu B, Liang A, Cao L, Tong X, Lu X, Wu MC and Guo YJ: Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 51: 142-153, 2010.
15. Chen JF, Xie F, Zhang LJ and Jiang WG: iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer 10: 694, 2010.